HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Moreira Selected Research

Therapeutics

9/2020An overview of lipidomic analysis in different human matrices of multiple sclerosis.
1/2018Efficacy and effectiveness of omalizumab in the treatment of childhood asthma.
1/2012Treatment of thalidomide resistant pyoderma gangrenosum with etenercept.
5/2009Description and management of cutaneous side effects during erlotinib and cetuximab treatment in lung and colorectal cancer patients: a prospective and descriptive study of 19 patients.
4/2008Analysis of the dynamics and origin of epileptic activity in patients with tuberous sclerosis evaluated for surgery of epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Moreira Research Topics

Disease

3Asthma (Bronchial Asthma)
01/2021 - 01/2018
2Inflammation (Inflammations)
01/2017 - 01/2012
2Epilepsy (Aura)
04/2008 - 09/2003
1Multiple Sclerosis
09/2020
1Pruritus (Itching)
08/2020
1Obesity
01/2019
1Overweight
01/2019
1Bronchiolitis
05/2017
1Viral Bronchiolitis
05/2017
1Infections
05/2017
1Coinfection
05/2017
1Paresthesia (Dysesthesia)
01/2012
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2012
1Rheumatoid Arthritis
01/2012
1Hypesthesia (Numbness)
01/2012
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2012
1Ankylosing Spondylitis
01/2012
1Psoriatic Arthritis
01/2012
1Pyoderma Gangrenosum
01/2012
1Cicatrix (Scar)
04/2011
1Herpes Simplex Encephalitis (Herpes Encephalitis)
03/2011
1Rhinophyma
04/2010
1Erythema
04/2010
1Telangiectasis (Telangiectasia)
04/2010
1Rosacea (Acne Rosacea)
09/2009
1Colorectal Neoplasms (Colorectal Cancer)
05/2009
1Exanthema (Rash)
05/2009
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2009
1Tuberous Sclerosis (Bourneville's Disease)
04/2008
1Hypothalamic hamartomas
09/2003

Drug/Important Bio-Agent (IBA)

3Omalizumab (Xolair)FDA Link
01/2021 - 01/2018
2LipidsIBA
09/2020 - 01/2019
2Immunoglobulin E (IgE)IBA
01/2020 - 01/2018
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018
1Monoclonal AntibodiesIBA
01/2018
1Thymic Stromal LymphopoietinIBA
05/2017
1Interleukin-33IBA
05/2017
1PeriostinIBA
05/2017
1Fatty Acids (Saturated Fatty Acids)IBA
01/2017
1Etanercept (Enbrel)FDA Link
01/2012
1Pharmaceutical PreparationsIBA
01/2012
1Thalidomide (Thalomid)FDA Link
01/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012
1CytokinesIBA
01/2012
1InterferonsIBA
03/2011
1Carbon DioxideIBA
04/2010
1ErbB Receptors (EGF Receptor)IBA
05/2009
1Erlotinib Hydrochloride (CP 358,774)FDA Link
05/2009
1Cetuximab (Erbitux)FDA Link
05/2009
1trans-sodium crocetinate (crocetin)IBA
04/2008

Therapy/Procedure

5Therapeutics
09/2020 - 04/2008
3Dye Lasers
04/2011 - 09/2009
2Drug Therapy (Chemotherapy)
05/2009 - 09/2003
1Hypnosis (Mesmerism)
08/2020
1Length of Stay
05/2017
1Gas Lasers
04/2010